( RICS:LUPN )

News from Lupin Ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 06, 2016, 09:15 ET Lupin and MonoSol Rx Announce Licensing Agreement for Multiple Pediatric-focused Products

Lupin Pharmaceutical Inc., the US subsidiary of pharma major Lupin Limited (collectively Lupin) and MonoSol Rx, a specialty pharmaceutical...


Apr 28, 2016, 13:23 ET Lupin Bolsters US Brands Portfolio with Methergine® Oral Tablets

The only FDA-approved oral uterotonic for the management of PPH, comes to market with a significant investment in professional medical...


Apr 05, 2016, 13:01 ET Lupin Launches Generic Intermezzo® Sublingual Tablets in the US

Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the first product...


Mar 09, 2016, 09:25 ET Lupin Completes its Acquisition of GAVIS

Pharma Major Lupin Limited (Lupin) announced today that it has completed its acquisition of privately held US based GAVIS Pharmaceuticals LLC and...


Feb 02, 2016, 09:30 ET Lupin Launches Generic Glumetza® HCI ER Tablets in the US

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc., has launched its Metformin HCl ER Tablets,...


Jan 06, 2016, 09:34 ET Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets in the US

Pharma Major Lupin Limited (Lupin) announced that its US subsidiary Lupin Pharmaceutical Inc. has launched its Tri-Lo-Marzia™...


Nov 06, 2015, 08:10 ET Lupin ernennt Thierry Volle zum Leiter der Region Europa, Naher Osten und Afrika (EMEA)

Das große Pharmaunternehmen Lupin Limited gab heute die Ernennung von Thierry Volle zum Leiter der Region Europa, Naher Osten und Afrika...


Nov 05, 2015, 23:08 ET Lupin nomme Thierry Volle au poste de président pour l'Europe, le Moyen-Orient et l'Afrique (EMEA)

Le géant pharmaceutique Lupin Limited annonce ce jour la nomination de Thierry Volle à titre de président pour l'Europe, le...


Nov 05, 2015, 07:03 ET Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)

Pharma major Lupin Limited today announced the appointment of Thierry Volle as President of Europe, Middle-East & Africa (EMEA). At Lupin,...


Sep 03, 2015, 11:32 ET Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US

Pharma major Lupin Limited announced today that its subsidiary Lupin Pharmaceuticals, Inc. (Lupin) has launched its Duloxetine 40 mg...


Feb 18, 2015, 06:40 ET Lupin et Celon ont conclu un accord de licence dans le cadre d'un développement stratégique pour le générique d'Advair Diskus®

La société pharmaceutique de premier plan, Lupin Limited (Lupin), et Celon Pharma S.A. (Celon) ont annoncé aujourd'hui avoir conclu...


Feb 18, 2015, 05:35 ET Lupin und Celon geben strategische Zusammenarbeit und Lizenzvereinbarung für das Generikum Advair Diskus® bekannt

Der führende Pharmahersteller Lupin Limited (Lupin) und Celon Pharma S.A. (Celon) geben heute bekannt, dass sie einen Vertrag unterzeichnet...


Feb 17, 2015, 06:35 ET Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskus®

Pharma Major Lupin Limited (Lupin) and Celon Pharma S.A. (Celon) announced today that they have entered into a definitive agreement under which...


Jan 06, 2015, 13:41 ET Lupin Launches Generic DIOVAN® Tablets

Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched its Valsartan...


Dec 11, 2014, 07:52 ET Lupin Launches Authorized Genericfor Celebrex® Capsules

Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized...


Mar 27, 2014, 17:42 ET Lupin adquiere Laboratorios Grin S.A. de C.V., México

Pharma Major Lupin Limited anunció hoy la adquisición del 100% del capital accionario en Laboratorios Grin, S.A. de C.V. (Grin),...


Mar 27, 2014, 16:28 ET Lupin adquire Laboratorios Grin S.A. De C.V., México

A gigante farmacêutica Lupin Limited anunciou hoje a aquisição de 100% das ações dos Laboratorios Grin, S.A. De C.V....


Mar 27, 2014, 12:24 ET Lupin Acquires Laboratorios Grin S.A. De C.V., Mexico

Pharma Major Lupin Limited announced today the acquisition of 100% equity stake in Laboratorios Grin, S.A. De C.V. (Grin), Mexico, subject to...


Feb 19, 2014, 09:52 ET Lupin ernennt Dr. Maurice Chagnaud zum Präsident für Europa und Leiter der Inhalationsstrategie

Pharmakonzern Lupin hat heute die Ernennung von Dr. Maurice Chagnaud als Präsident für Europa und Leiter der Inhalationsstrategie...


Feb 18, 2014, 13:54 ET Lupin nombra a Maurice Chagnaud presidente de Europa y director de estrategia de inhalación

La farmacéutica Lupin ha anunciado hoy el nombramiento del doctor Maurice Chagnaud como presidente de Europa y director de estrategia de...


Feb 18, 2014, 12:40 ET Le Dr Maurice Chagnaud nommé président Europe et responsable de la stratégie pour la division Inhalation de Lupin

La société pharmaceutique de premier plan Lupin a annoncé aujourd'hui la nomination du Dr Maurice Chagnaud au poste de...


Feb 18, 2014, 08:05 ET Lupin Appoints Dr. Maurice Chagnaud as President-Europe & Head of Inhalation Strategy

Pharma major Lupin, today announced the appointment of Dr. Maurice Chagnaud as its President, Europe and Head of Inhalation Strategy. He will be...


Feb 03, 2014, 10:59 ET Lupin Ltd: Strong Growth, Record Profits - Quarter III Results, FY 2013-14

Net Sales up 21%; EBITDA up 28%; Net profit up 42% Declares Interim Dividend of 150 % Lupin Limited reported its performance for the third...


Dec 18, 2013, 10:26 ET Lupin Launches Generic Trizivir® Tablets in the US

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary Lupin Pharmaceuticals Inc. has launched its Abacavir Sulfate,...


Dec 12, 2013, 12:08 ET Lupin Launches Generic Cymbalta® Delayed-Release Capsules 20 mg, 30 mg and 60 mg Strengths in the US

Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has launched its Duloxetine...